Cargando…
Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study
Objectives: Stereotactic body radiation therapy (SBRT) yields excellent disease control for low- and intermediate-risk prostate cancer by delivering high doses of radiation in a small number of fractions. Our report presents a 7-year update on treatment toxicity and quality of life (QOL) from 515 pa...
Autores principales: | Katz, Alan Jay, Kang, Josephine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211385/ https://www.ncbi.nlm.nih.gov/pubmed/25389521 http://dx.doi.org/10.3389/fonc.2014.00301 |
Ejemplares similares
-
Stereotactic Body Radiotherapy as Treatment for Organ Confined Low- and Intermediate-Risk Prostate Carcinoma, a 7-Year Study
por: Katz, Alan Jay, et al.
Publicado: (2014) -
SBRT: An Opportunity to Improve Quality of Life for Oligometastatic Prostate Cancer
por: Azzam, Gregory, et al.
Publicado: (2015) -
Prostate SBRT: Comparison the Efficacy and Toxicity of Two Different Dose Fractionation Schedules
por: Fuller, Donald Blake, et al.
Publicado: (2020) -
Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT
por: Iocolano, Michelle, et al.
Publicado: (2020) -
Virtual HDR CyberKnife SBRT for Localized Prostatic Carcinoma: 5-Year Disease-Free Survival and Toxicity Observations
por: Fuller, Donald Blake, et al.
Publicado: (2014)